Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Value of the new bone classification system in pediatric renal osteodystrophy.

Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, Salusky IB.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1860-6. doi: 10.2215/CJN.01330210. Epub 2010 Jul 15.

2.

Value of the new bone classification system for pediatric patients with chronic kidney disease.

Jorgetti V, Drüeke TB.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1730-1. doi: 10.2215/CJN.07620810. Epub 2010 Sep 28. No abstract available.

3.

Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3 - 5.

Lehmann G, Ott U, Kaemmerer D, Schuetze J, Wolf G.

Clin Nephrol. 2008 Oct;70(4):296-305.

PMID:
18826854
4.

Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.

Haarhaus M, Monier-Faugere MC, Magnusson P, Malluche HH.

Am J Kidney Dis. 2015 Jul;66(1):99-105. doi: 10.1053/j.ajkd.2015.02.323. Epub 2015 Apr 2.

5.

Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.

Pereira RC, Bischoff DS, Yamaguchi D, Salusky IB, Wesseling-Perry K.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):481-7. doi: 10.2215/CJN.04810515. Epub 2015 Dec 28.

6.

Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.

Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F.

Nephrol Dial Transplant. 1998 Sep;13(9):2294-302.

PMID:
9761512
7.

Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry.

Ferreira A, Saraiva M, Behets G, Macedo A, Galvão M, D'Haese P, Drüeke TB.

J Nephrol. 2009 Nov-Dec;22(6):783-93.

PMID:
19967658
8.

Serum phosphorus adds to value of serum parathyroid hormone for assessment of bone turnover in renal osteodystrophy.

Gentry J, Webb J, Davenport D, Malluche HH.

Clin Nephrol. 2016 Jul;86(7):9-17. doi: 10.5414/CN108823.

PMID:
27191663
9.

Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.

Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG.

Kidney Int. 1994 Jan;45(1):253-8.

10.

[Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis].

Rojas González AM, Opazo Valenzuela M, Muñoz Navarro S.

Medwave. 2014 Sep 3;14(8):e6014. doi: 10.5867/medwave.2014.08.6014. Spanish.

PMID:
25340338
11.

Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.

De Paola L, Coppolino G, Bolignano D, Buemi M, Lombardi L.

Ther Apher Dial. 2010 Dec;14(6):566-71. doi: 10.1111/j.1744-9987.2010.00822.x.

PMID:
21118364
12.

Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.

Baskin E, Beşbaş N, Saatçi U, Hasçelik G, Topaloğlu R, Ozen S, Bakkaloğlu A.

Turk J Pediatr. 2004 Jan-Mar;46(1):28-31.

PMID:
15074371
13.

Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis.

Gokal R, Ramos JM, Ellis HA, Parkinson I, Sweetman V, Dewar J, Ward MK, Kerr DN.

Kidney Int. 1983 Jan;23(1):15-21. No abstract available.

14.
15.

Bone disease in patients with long-term renal transplantation and normal renal function.

Carlini RG, Rojas E, Weisinger JR, Lopez M, Martinis R, Arminio A, Bellorin-Font E.

Am J Kidney Dis. 2000 Jul;36(1):160-6.

PMID:
10873886
16.

[Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].

Ziółkowska H, Roszkowska-Blaim M.

Przegl Lek. 2006;63 Suppl 3:149-52. Polish.

PMID:
16898516
17.

Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.

Avila-Díaz M, Matos M, García-López E, Prado MD, Castro-Vázquez F, Ventura MD, González E, Amato D, Paniagua R.

Perit Dial Int. 2006 Jan-Feb;26(1):78-84.

PMID:
16538879
18.

Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.

Lehmann G, Stein G, Hüller M, Schemer R, Ramakrishnan K, Goodman WG.

Kidney Int. 2005 Sep;68(3):1206-14.

19.

Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.

Sprague SM, Bellorin-Font E, Jorgetti V, Carvalho AB, Malluche HH, Ferreira A, D'Haese PC, Drüeke TB, Du H, Manley T, Rojas E, Moe SM.

Am J Kidney Dis. 2016 Apr;67(4):559-66. doi: 10.1053/j.ajkd.2015.06.023. Epub 2015 Aug 25.

PMID:
26321176
20.

Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.

Ureña P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC.

J Am Soc Nephrol. 1996 Mar;7(3):506-12.

Supplemental Content

Support Center